ClinVar Miner

Submissions for variant NM_000135.4(FANCA):c.487C>T (p.Arg163Cys)

gnomAD frequency: 0.00001  dbSNP: rs747651383
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV001050935 SCV001215066 uncertain significance Fanconi anemia 2022-07-18 criteria provided, single submitter clinical testing This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 163 of the FANCA protein (p.Arg163Cys). This variant is present in population databases (rs747651383, gnomAD 0.009%). This variant has not been reported in the literature in individuals affected with FANCA-related conditions. ClinVar contains an entry for this variant (Variation ID: 847400). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
GeneDx RCV001772256 SCV001992350 uncertain significance not provided 2019-04-17 criteria provided, single submitter clinical testing Has not been previously published as pathogenic or benign to our knowledge
Sema4, Sema4 RCV001050935 SCV002535059 uncertain significance Fanconi anemia 2021-05-18 criteria provided, single submitter curation
Fulgent Genetics, Fulgent Genetics RCV001274659 SCV002786016 uncertain significance Fanconi anemia complementation group A 2021-08-26 criteria provided, single submitter clinical testing
Quest Diagnostics Nichols Institute San Juan Capistrano RCV001772256 SCV004218622 uncertain significance not provided 2023-01-03 criteria provided, single submitter clinical testing The variant has not been reported in the published literature. The frequency of this variant in the general population, 0.000087 (3/34590 chromosomes, http://gnomad.broadinstitute.org), is uninformative in assessment of its pathogenicity. Analysis of this variant using bioinformatics tools for the prediction of the effect of amino acid changes on protein structure and function yielded conflicting predictions that this variant is benign or damaging. Based on the available information, we are unable to determine the clinical significance of this variant.
Natera, Inc. RCV001274659 SCV001459013 uncertain significance Fanconi anemia complementation group A 2020-09-16 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.